Cloned (Comment) | Organism |
---|---|
sEH expression in HEK-293 cells under the control of the cytomegalo virus promoter, tissue expression analysis by real-time quantitative reverse transcription PCR | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-adamantyl-3-cyclohexylurea | - |
Homo sapiens | |
1-adamantyl-3-cyclohexylurea | - |
Mus musculus | |
cis-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid | - |
Homo sapiens | |
cis-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid | - |
Mus musculus | |
additional information | the EET antagonist, 14,15-EEZE at 10 mM attenuates the increase in pulmonary artery pressure in the absence of the sEH inhibitor and completely prevents the increased constriction induced by 1-adamantyl-3-cyclohexylurea. Prolonged sEH inhibition results in significantly elevated serum levels of 5,6-, 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids/dihydroxyeicosatrienoic acids but fails to affect the ratio of the right/left ventricle and septum | Mus musculus | |
trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid | - |
Homo sapiens | |
trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid | - |
Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
soluble | - |
Mus musculus | - |
- |
soluble | - |
Homo sapiens | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | Mus musculus | - |
(5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | Homo sapiens | - |
(5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | Mus musculus C57BL/6 | - |
(5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P34913 | - |
- |
Mus musculus | P34914 | C57BL/6 mice | - |
Mus musculus C57BL/6 | P34914 | C57BL/6 mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
lung | immunohistochemical analysis showing the expression of the sEH in lungs from wild-type mice kept under normoxic conditions or after exposure to 21 days hypoxia, overview | Mus musculus | - |
lung | sEH is expressed in the wall of pulmonary arteries, however, sEH expression is absent in samples from patients with pulmonary hypertension | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | - |
Mus musculus | (5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | - |
Homo sapiens | (5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | - |
Mus musculus C57BL/6 | (5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
additional information | the C-terminal domain of the soluble epoxide hydrolase metabolizes epoxyeicosatrienoic acids, EETs, to their less active diols, while the N-terminal domain demonstrates lipid phosphatase activity | Mus musculus | ? | - |
? | |
additional information | the C-terminal domain of the soluble epoxide hydrolase metabolizes epoxyeicosatrienoic acids, EETs, to their less active diols, while the N-terminal domain demonstrates lipid phosphatase activity | Homo sapiens | ? | - |
? | |
additional information | the C-terminal domain of the soluble epoxide hydrolase metabolizes epoxyeicosatrienoic acids, EETs, to their less active diols, while the N-terminal domain demonstrates lipid phosphatase activity | Mus musculus C57BL/6 | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SEH | - |
Mus musculus |
SEH | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | acute hypoxic vasoconstriction in sEH-/- mice is insensitive to sEH inhibition but inhibited by the epoxyeicosatrienoic acid antagonist, and chronic hypoxia induces an exaggerated pulmonary vascular remodelling. In wild-type mice, chronic sEH inhibition increases serum epoxyeicosatrienoic acid levels but fails to affect acute hypoxic vasoconstriction, right ventricle weight, pulmonary artery muscularization, or voluntary running distance | Mus musculus |
malfunction | sEH expression is absent in samples from patients with pulmonary hypertension. As sEH inhibitors do not promote the development of pulmonary hypertension it seems likely that the N-terminal lipid phosphatase may play a role in the development of this disease | Homo sapiens |